XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Financial Instruments (Tables)
3 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Cash Equivalents and Marketable Securities

The Company’s cash equivalents and marketable securities at June 30, 2022 and March 31, 2022 are invested in the following:

 

 

 

Amortized

 

 

Gross
Unrealized

 

 

Gross
Unrealized

 

 

Fair Market

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

June 30, 2022

 

(in thousands)

 

Money market funds

 

$

59,296

 

 

$

 

 

$

 

 

$

59,296

 

Commercial paper

 

 

5,997

 

 

 

 

 

 

(2

)

 

 

5,995

 

Total cash equivalents

 

 

65,293

 

 

 

 

 

 

(2

)

 

 

65,291

 

Short-term U.S. Treasury mutual fund securities

 

 

359,213

 

 

 

 

 

 

(3,010

)

 

 

356,203

 

Short-term government-backed securities

 

 

160,288

 

 

 

1

 

 

 

(1,875

)

 

 

158,414

 

Short-term corporate debt securities

 

 

33,110

 

 

 

 

 

 

(179

)

 

 

32,931

 

Short-term commercial paper

 

 

116,738

 

 

 

 

 

 

(457

)

 

 

116,281

 

Total short-term marketable securities

 

 

669,349

 

 

 

1

 

 

 

(5,521

)

 

 

663,829

 

Long-term U.S. Treasury mutual fund securities

 

 

48,631

 

 

 

 

 

 

(1,428

)

 

 

47,203

 

Long-term government-backed securities

 

 

105,838

 

 

 

 

 

 

(3,026

)

 

 

102,812

 

Long-term corporate debt securities

 

 

10,185

 

 

 

 

 

 

(324

)

 

 

9,861

 

Total long-term marketable securities

 

 

164,654

 

 

 

 

 

 

(4,778

)

 

 

159,876

 

Total cash equivalents and marketable securities

 

$

899,296

 

 

$

1

 

 

$

(10,301

)

 

$

888,996

 

 

 

 

Amortized

 

 

Gross
Unrealized

 

 

Gross
Unrealized

 

 

Fair Market

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

March 31, 2022:

 

(in thousands)

 

Money market funds

 

$

32,955

 

 

$

 

 

$

 

 

$

32,955

 

Commercial paper

 

 

28,961

 

 

 

 

 

 

(3

)

 

 

28,958

 

Total cash equivalents

 

 

61,916

 

 

 

 

 

 

(3

)

 

 

61,913

 

Short-term U.S. Treasury mutual fund securities

 

 

287,010

 

 

 

 

 

 

(1,384

)

 

 

285,626

 

Short-term government-backed securities

 

 

131,954

 

 

 

1

 

 

 

(554

)

 

 

131,401

 

Short-term corporate debt securities

 

 

61,108

 

 

 

36

 

 

 

(113

)

 

 

61,031

 

Short-term commercial paper

 

 

148,128

 

 

 

 

 

 

(397

)

 

 

147,731

 

Total short-term marketable securities

 

 

628,200

 

 

 

37

 

 

 

(2,448

)

 

 

625,789

 

Long-term U.S. Treasury mutual fund securities

 

 

89,168

 

 

 

 

 

 

(1,796

)

 

 

87,372

 

Long-term government-backed securities

 

 

126,150

 

 

 

 

 

 

(3,378

)

 

 

122,772

 

Long-term corporate debt securities

 

 

10,226

 

 

 

 

 

 

(281

)

 

 

9,945

 

Total long-term marketable securities

 

 

225,544

 

 

 

 

 

 

(5,455

)

 

 

220,089

 

Total cash equivalents and marketable securities

 

$

915,660

 

 

$

37

 

 

$

(7,906

)

 

$

907,791

 

Schedule of Cross-Currency Rate Swap Derivatives Agreement

The following table summarizes the terms of the cross-currency swap agreement as of June 30, 2022 (amounts in thousands):

 

 

 

 

 

 

 

 

 

 

 

Effective Date

 

Maturity

 

Fixed Rate

 

Aggregate Notional Amount

 

Pay EUR

October 15, 2019

 

October 15, 2024

 

2.75%

 

 

EUR 85,000

 

Receive U.S.$

 

 

 

 

4.64%

 

 

USD 93,457

 

Schedule of Fair Value of Company's Derivative Instrument

The following table presents the fair value of the cross-currency swap (amounts in thousands):

 

Derivatives designated as hedging instruments under ASC 815

 

Balance Sheet classification

 

June 30, 2022

 

 

March 31, 2022

 

Cross-currency swap

 

Other assets (other long-term liabilities)

 

$

4,508

 

 

$

(489

)

Financial Instruments Measured at Fair Value

The following tables present the Company’s assets and liabilities measured at fair value on a recurring basis:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

June 30, 2022:

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

59,296

 

 

$

 

 

$

 

 

$

59,296

 

Commercial paper

 

 

 

 

 

5,995

 

 

 

 

 

 

5,995

 

Short-term U.S. Treasury mutual fund securities

 

 

 

 

 

356,203

 

 

 

 

 

 

356,203

 

Short-term government-backed securities

 

 

 

 

 

158,414

 

 

 

 

 

 

158,414

 

Short-term corporate debt securities

 

 

 

 

 

32,931

 

 

 

 

 

 

32,931

 

Short-term commercial paper

 

 

 

 

 

116,281

 

 

 

 

 

 

116,281

 

Long-term U.S. Treasury mutual fund securities

 

 

 

 

 

47,203

 

 

 

 

 

 

47,203

 

Long-term government-backed securities

 

 

 

 

 

102,812

 

 

 

 

 

 

102,812

 

Long-term corporate debt securities

 

 

 

 

 

9,861

 

 

 

 

 

 

9,861

 

Investment in Shockwave Medical

 

 

56,730

 

 

 

 

 

 

 

 

 

56,730

 

Cross-currency swap agreement

 

 

 

 

 

4,508

 

 

 

 

 

 

4,508

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

 

 

 

 

 

 

 

18,151

 

 

 

18,151

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

March 31, 2022:

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

32,955

 

 

$

 

 

$

 

 

$

32,955

 

Commercial paper

 

 

 

 

 

28,958

 

 

 

 

 

 

28,958

 

Short-term U.S. Treasury mutual fund securities

 

 

 

 

 

285,626

 

 

 

 

 

 

285,626

 

Short-term government-backed securities

 

 

 

 

 

131,401

 

 

 

 

 

 

131,401

 

Short-term corporate debt securities

 

 

 

 

 

61,031

 

 

 

 

 

 

61,031

 

Short-term commercial paper

 

 

 

 

 

147,731

 

 

 

 

 

 

147,731

 

Long-term U.S. Treasury mutual fund securities

 

 

 

 

 

87,372

 

 

 

 

 

 

87,372

 

Long-term government-backed securities

 

 

 

 

 

122,772

 

 

 

 

 

 

122,772

 

Long-term corporate debt securities

 

 

 

 

 

9,945

 

 

 

 

 

 

9,945

 

Investment in Shockwave Medical

 

 

61,535

 

 

 

 

 

 

 

 

 

61,535

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Cross-currency swap agreement

 

 

 

 

 

489

 

 

 

 

 

 

489

 

Contingent consideration

 

 

 

 

 

 

 

 

21,510

 

 

 

21,510

 

Schedule Of Portfolio Of Equity Method and Other Investments and Change in Balance The carrying value of the Company’s portfolio of other investments and the change in the balance for the three months ended June 30, 2022 are as follows:

 

 

 

 

 

 

 

(in thousands)

 

Balance, March 31, 2022

 

$

70,314

 

Additions

 

 

4,591

 

Change in fair value, net

 

 

4,731

 

Balance, June 30, 2022

 

$

79,636

 

Components of Contingent Consideration Liabilities

The components of contingent consideration are as follows:

 

 

 

June 30, 2022

 

 

March 31, 2022

 

 

 

(in thousands)

 

ECP

 

$

11,651

 

 

$

12,010

 

Breethe

 

 

6,500

 

 

 

9,500

 

Total contingent consideration

 

$

18,151

 

 

$

21,510

 

Change in Fair Value of Contingent Consideration as Determined by Level 3 Inputs

The following table summarizes the change in fair value, as determined by Level 3 inputs of the contingent consideration for the three months ended June 30, 2022:

 

 

 

 

 

 

 

(in thousands)

 

Balance, March 31, 2022

$

21,510

 

Change in fair value

 

(3,359

)

Balance, June 30, 2022

$

18,151